170 related articles for article (PubMed ID: 6297383)
1. Tromantadine: inhibitor of early and late events in herpes simplex virus replication.
Rosenthal KS; Sokol MS; Ingram RL; Subramanian R; Fort RC
Antimicrob Agents Chemother; 1982 Dec; 22(6):1031-6. PubMed ID: 6297383
[TBL] [Abstract][Full Text] [Related]
2. Tromantadine inhibits a late step in herpes simplex virus type 1 replication and syncytium formation.
Ickes DE; Venetta TM; Phonphok Y; Rosenthal KS
Antiviral Res; 1990 Aug; 14(2):75-85. PubMed ID: 2177318
[TBL] [Abstract][Full Text] [Related]
3. In vitro antiviral activity of Chamaecrista nictitans (Fabaceae) against herpes simplex virus: biological characterization of mechanisms of action.
Herrero Uribe L; Chaves Olarte E; Tamayo Castillo G
Rev Biol Trop; 2004 Sep; 52(3):807-16. PubMed ID: 17361573
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the interaction of the anti-viral chemotherapeutic agents amantadine and tromantadine with model phospholipid membranes.
Cheetham JJ; Epand RM
Biosci Rep; 1987 Mar; 7(3):225-30. PubMed ID: 3663887
[TBL] [Abstract][Full Text] [Related]
5. Development and evaluation of a host-targeted antiviral that abrogates herpes simplex virus replication through modulation of arginine-associated metabolic pathways.
Sanchez MD; Ochoa AC; Foster TP
Antiviral Res; 2016 Aug; 132():13-25. PubMed ID: 27192555
[TBL] [Abstract][Full Text] [Related]
6. Characterization of inhibitory action of concanamycins against herpes simplex virus.
Hayashi K; Kawauchi M; Nakai C; Sankawa U; Seto H; Hayashi T
Antivir Chem Chemother; 2001 Jan; 12(1):51-9. PubMed ID: 11437322
[TBL] [Abstract][Full Text] [Related]
7. Cell culture replication of herpes simplex virus and, or human cytomegalovirus is inhibited by 3,7-dialkoxylated, 1-hydroxyacridone derivatives.
Lowden CT; Bastow KF
Antiviral Res; 2003 Aug; 59(3):143-54. PubMed ID: 12927304
[TBL] [Abstract][Full Text] [Related]
8. [Contact allergy to tromantadine].
Agathos M; Remien C; Mutzeck E
Derm Beruf Umwelt; 1984; 32(5):157-60. PubMed ID: 6239766
[TBL] [Abstract][Full Text] [Related]
9. Herpes simplex virus latency in cultured human cells following treatment with cytosine arabinoside.
O'Neill FJ; Goldberg RJ; Rapp F
J Gen Virol; 1972 Feb; 14(2):189-97. PubMed ID: 4334781
[No Abstract] [Full Text] [Related]
10. Herpes simplex type1:lacZ recombinant viruses. II. Microtiter plate-based colorimetric assays for the discovery of new antiherpes agents and the points at which such agents disrupt the viral replication cycle.
Dicker IB; Blasecki JW; Seetharam S
Antiviral Res; 1995 Nov; 28(3):213-24. PubMed ID: 8629814
[TBL] [Abstract][Full Text] [Related]
11. Tromantadine hydrochloride in the treatment of herpes simplex. Results of a double-blind therapeutic trial and an open prophylactic investigation.
Hellgren L; Hermann LS
Dermatologica; 1983; 167(5):267-72. PubMed ID: 6360739
[TBL] [Abstract][Full Text] [Related]
12. In vitro antiviral activity of a saponin from Anagallis arvensis, Primulaceae, against herpes simplex virus and poliovirus.
Amoros M; Fauconnier B; Girre RL
Antiviral Res; 1987 Aug; 8(1):13-25. PubMed ID: 2825589
[TBL] [Abstract][Full Text] [Related]
13. In vitro antiviral activity of polyoxotungstate (PM-19) and other polyoxometalates against herpes simplex virus.
Fukuma M; Seto Y; Yamase T
Antiviral Res; 1991 Dec; 16(4):327-39. PubMed ID: 1663733
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of action of the antiherpesvirus biflavone ginkgetin.
Hayashi K; Hayashi T; Morita N
Antimicrob Agents Chemother; 1992 Sep; 36(9):1890-3. PubMed ID: 1329635
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of herpes simplex virus replication by phosphonoacetic acid.
Overby LR; Robishaw EE; Schleicher JB; Rueter A; Shipkowitz NL; Mao JC
Antimicrob Agents Chemother; 1974 Sep; 6(3):360-5. PubMed ID: 15830487
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of herpes simplex virus replication by anthracycline compounds.
Ash RJ; Diekema KA
Antiviral Res; 1987 Sep; 8(2):71-83. PubMed ID: 2830845
[TBL] [Abstract][Full Text] [Related]
17. Antiviral Effects of ABMA against Herpes Simplex Virus Type 2 In Vitro and In Vivo.
Dai W; Wu Y; Bi J; Wang S; Li F; Kong W; Barbier J; Cintrat JC; Gao F; Gillet D; Su W; Jiang C
Viruses; 2018 Mar; 10(3):. PubMed ID: 29522484
[TBL] [Abstract][Full Text] [Related]
18. Yucca leaf protein (YLP) stops the protein synthesis in HSV-infected cells and inhibits virus replication.
Hayashi K; Nishino H; Niwayama S; Shiraki K; Hiramatsu A
Antiviral Res; 1992 Apr; 17(4):323-33. PubMed ID: 1322646
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of herpes simplex virus DNA synthesis by pokeweed antiviral protein.
Teltow GJ; Irvin JD; Aron GM
Antimicrob Agents Chemother; 1983 Mar; 23(3):390-6. PubMed ID: 6303210
[TBL] [Abstract][Full Text] [Related]
20. The antiviral agent 5-chloro-1,3-dihydroxyacridone interferes with assembly and maturation of herpes simplex virus.
Akanitapichat P; Bastow KF
Antiviral Res; 2002 Feb; 53(2):113-26. PubMed ID: 11750937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
